Differential Effects of Genetically Determined Cholesterol Efflux Capacity on Coronary Artery Disease and Ischemic Stroke

被引:0
|
作者
Jin, Aoming [1 ,2 ]
Wang, Mengxing [1 ,2 ]
Chen, Weiqi [1 ,2 ]
Yan, Hongyi [1 ,2 ]
Xiang, Xianglong [1 ,2 ]
Pan, Yuesong [1 ,2 ]
机构
[1] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Tiantan Hosp, China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China
来源
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2022年 / 9卷
基金
中国国家自然科学基金;
关键词
cholesterol efflux capacity; Mendelian randomization; coronary artery disease; stroke; genetics; HIGH-DENSITY-LIPOPROTEIN; MENDELIAN RANDOMIZATION; CARDIOVASCULAR RISK; HDL CHOLESTEROL; EVENTS; ASSOCIATION; INSTRUMENTS; METAANALYSIS; BIAS;
D O I
10.3389/fcvm.2022.891148
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundObservational studies indicated that cholesterol efflux capacity (CEC) of high-density lipoprotein (HDL) is inversely associated with cardiovascular events, independently of the HDL cholesterol concentration. The aim of the study is to examine the casual relevance of CEC for coronary artery disease (CAD) and myocardial infarction (MI), and compare it with that for ischemic stroke and its subtypes using a Mendelian randomization approach. MethodsWe performed a 2-sample Mendelian randomization to estimate the casual relationship of CEC with the risk of CAD, MI, and ischemic stroke. A CEC-related genetic variant (rs141622900) and other five genetic variants were used as the instrumental variables. Association of genetic variants with CAD were estimated in a GWAS involving 60,801 CAD cases and 123,504 controls. They were then compared with the associations of these variants with ischemic stroke and its subtypes (large vessel, small vessel, and cardioembolic) involving 40,585 ischemic stroke cases and 406,111 controls. ResultsUsing the SNP of rs141622900 as the instrument, a 1-SD increase in CEC was associated with 45% lower risk for CAD (odds ratio [OR] 0.55, 95% confidence interval [CI] 0.44-0.69, p < 0.001) and 33% lower risk for MI (odds ratio [OR] 0.67, 95% CI 0.52-0.87, p = 0.002). By contrast, the causal effect of CEC was much weaker for ischemic stroke (odds ratio [OR] 0.79, 95% CI 0.64-0.97, p = 0.02; p for heterogeneity = 0.03) and, in particular, for cardioembolic stroke (p for heterogeneity = 0.006) when compared with that for CAD. Results using five genetic variants as the instrument also indicated consistently weaker effects on ischemic stroke than on CAD. ConclusionGenetic predicted higher CEC may be associated with decreased risk of CAD. However, the casual association of CEC with ischemic stroke and specific subtypes would need to be validated in further Mendelian randomization studies.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Cholesterol mass efflux capacity and coronary artery calcium: The Multi-Ethnic Study of Atherosclerosis
    Garg, Parveen K.
    Tressel, William
    McClelland, Robyn L.
    Criqui, Michael H.
    Stein, James H.
    Yvan-Chavret, Laurent
    Tall, Alan R.
    Shea, Steven
    JOURNAL OF CLINICAL LIPIDOLOGY, 2022, 16 (06) : 895 - 900
  • [22] Cholesterol Uptake Capacity as a Prognostic Marker of Cardiovascular Events for Patients with Coronary Artery Disease
    Yoshikawa, Yusuke
    Toh, Ryuji
    Murakami, Katsuhiro
    Harada, Amane
    Kim, Jeeeun
    Kobayash, Yuto
    Miwa, Keiko
    Nagao, Manabu
    Ishida, Tatsuro
    Hirata, Ken-Ichi
    Takegami, Misa
    Nishimura, Kunihiro
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2025,
  • [23] Effects of phytochemicals on macrophage cholesterol efflux capacity: Impact on atherosclerosis
    Soltani, Saba
    Boozari, Motahareh
    Cicero, Arrigo F. G.
    Jamialahmadi, Tannaz
    Sahebkar, Amirhossein
    PHYTOTHERAPY RESEARCH, 2021, 35 (06) : 2854 - 2878
  • [24] Cholesterol Efflux Capacity and Cardiovascular Disease: The Ludwigshafen Risk and Cardiovascular Health (LURIC) Study
    Ritsch, Andreas
    Duerr, Angela
    Kahler, Patrick
    Hunjadi, Monika
    Stojakovic, Tatjana
    Silbernagel, Guenther
    Scharnagl, Hubert
    Kleber, Marcus E.
    Maerz, Winfried
    BIOMEDICINES, 2020, 8 (11) : 1 - 13
  • [25] Asymptomatic Coronary Artery Disease in Japanese Patients With the Acute Ischemic Stroke
    Tagawa, Minoru
    Takeuchi, Shigekazu
    Nakamura, Yuichi
    Saeki, Makihiko
    Taniguchi, Yoshinori
    Ohno, Tsukasa
    Watanabe, Hiroyuki
    Ochiai, Yukie
    Kato, Kiminori
    Chinushi, Masaomi
    Aizawa, Yoshifusa
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2019, 28 (03): : 612 - 618
  • [26] Coronary Calcium Score for the Prediction of Asymptomatic Coronary Artery Disease in Patients With Ischemic Stroke
    Choi, Hye-Yeon
    Shin, Soo Jeong
    Yoo, Joonsang
    Lee, Kijeong
    Song, Dongbeom
    Kim, Young Dae
    Nam, Hyo Suk
    Lee, Kyung Yul
    Lee, Hye Sun
    Kim, Dong Joon
    Heo, Ji Hoe
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [27] HDL cholesterol efflux capacity and phospholipid content are associated with the severity of acute ischemic stroke and predict its outcome
    Papagiannis, Achilleas
    Gkolfinopoulou, Christina
    Tziomalos, Konstantinos
    Dedemadi, Anastasia -Georgia
    Polychronopoulos, Georgios
    Milonas, Dimitrios
    Savopoulos, Christos
    Hatzitolios, Apostolos I.
    Chroni, Angeliki
    CLINICA CHIMICA ACTA, 2023, 540
  • [28] Acute ischemic coronary artery disease and ischemic stroke: Similarities and differences
    Fisher, Marc
    Folland, Edward
    AMERICAN JOURNAL OF THERAPEUTICS, 2008, 15 (02) : 137 - 149
  • [29] High-density lipoprotein cholesterol efflux capacity as a relevant predictor of atherosclerotic coronary disease
    Ishikawa, Tetsuya
    Ayaori, Makoto
    Uto-Kondo, Harumi
    Nakajima, Takatomo
    Mutoh, Makoto
    Ikewaki, Katsunori
    ATHEROSCLEROSIS, 2015, 242 (01) : 318 - 322
  • [30] Modulating cholesterol efflux capacity to improve cardiovascular disease
    Brownell, Nicholas
    Rohatgi, Anand
    CURRENT OPINION IN LIPIDOLOGY, 2016, 27 (04) : 398 - 407